Back
Sonnet BioTherapeutics Holdings Vs. Triumph Financial Industry Stock Comparison
Buy
55
SONN
Sonnet BioTherapeutics Holdings
Last Price:
0.71
Seasonality Move:
-4.68%
Sell
46
TFIN
Triumph Financial
Last Price:
78.51
Seasonality Move:
12.89%
Buy
55
Sonnet BioTherapeutics Holdings (SONN)
is a Buy
Is Sonnet BioTherapeutics Holdings a Buy, Sell or Hold?
- The current Sonnet BioTherapeutics Holdings [SONN] share price is $0.73. The Score for SONN is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- SONN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Triumph Financial (TFIN)
is a Sell
Is Triumph Financial a Buy, Sell or Hold?
- The current Triumph Financial [TFIN] share price is $77.20. The Score for TFIN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- TFIN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SONN Stock Price Chart
What is Sonnet BioTherapeutics Holdings's stock price today?
-
The Sonnet BioTherapeutics Holdings share price today is $0.73
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SONN is experiencing slight selling pressure.
TFIN Stock Price Chart
What is Triumph Financial's stock price today?
-
The Triumph Financial share price today is $77.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TFIN is experiencing selling pressure, which indicates risk of future bearish movement.
SONN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 39.68 | Sell |
| Chaikin Money Flow: | -32047 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.74 - 0.94) | Sell |
| Bollinger Bands (100): | (0.69 - 1.53) | Sell |
TFIN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.91 | Sell |
| Relative Strength Index (14 RSI): | 38 | Sell |
| Chaikin Money Flow: | -88106 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (79.12 - 83.7) | Sell |
| Bollinger Bands (100): | (74.95 - 85.81) | Sell |
SONN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.92 | Sell |
| 20-day SMA: | 0.86 | Sell |
| 50-day SMA: | 0.81 | Sell |
| 200-day SMA: | 1.41 | Sell |
| 8-day EMA: | 0.85 | Sell |
| 20-day EMA: | 0.85 | Sell |
| 50-day EMA: | 0.89 | Sell |
| 200-day EMA: | 2.83 | Sell |
TFIN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 80.91 | Sell |
| 20-day SMA: | 80.79 | Sell |
| 50-day SMA: | 83.23 | Sell |
| 200-day SMA: | 77.84 | Sell |
| 8-day EMA: | 79.9 | Sell |
| 20-day EMA: | 80.94 | Sell |
| 50-day EMA: | 81.64 | Sell |
| 200-day EMA: | 77.3 | Sell |
Sonnet BioTherapeutics Holdings Earnings Growth & SONN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.26 per share, an increase this year of $30.57 per share, and a decrease next year of $0.26 per share.
Triumph Financial Earnings Growth & TFIN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.37 per share, a decrease this year of $0.90 per share, and an increase next year of $1.31 per share.
Sonnet BioTherapeutics Holdings Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Triumph Financial Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||